Which hedge funds own IOVA? IOVANCE BIOTHERAPEUTICS INC, Q2 2026 13F holders
34 tracked hedge funds disclosed a position in IOVA (IOVANCE BIOTHERAPEUTICS INC) in their Q2 2026 13F filings, worth $351.0m in total. The largest holder by portfolio weight is MHR Fund Management LLC at 6.3% of its book. 9 opened a new position this quarter: Jupiter Asset Management Ltd, ADAR1 Capital Management, LLC, ExodusPoint Capital Management, LP, Brevan Howard Capital Management LP. 7 exited: Oxford Asset Management LLP, Arrowpoint Investment Partners (Singapore) Pte. Ltd., Quinn Opportunity Partners LLC.
- 34
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 7
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $21.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $1.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $351m
- Combined value Sum of the holders' reported positions in the security.
- 2.7%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Oxford Asset Management LLP | 0.1% | $284k |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 0.1% | $69.4k |
| Quinn Opportunity Partners LLC | 0.01% | $164k |
| Mirabella Financial Services LLP | 0.01% | $87.0k |
| Voleon Capital Management LP | 0.01% | $262k |
| Aquatic Capital Management LLC | 0.0% | $165k |
| Farallon Capital Management, L.L.C. | 0.0% | $91.3k |
Ownership over time
Who discovered IOVA first? Beta
The run: Q3 2025 → Q3 2026, +583%
| Great Point Partners LLC high conviction | Q1 2018 | – | +14.5 pts |
| Avoro Capital Advisors LLC high conviction | Q1 2018 | – | +6.4 pts |
| QVT Financial LP high conviction | Q2 2019 | 0.2% | +4.1 pts |
| Mangrove Partners IM, LLC | Q3 2019 | – | +1.5 pts |
| Orbimed Advisors LLC | Q2 2019 | – | +1.0 pts |
| Perceptive Advisors LLC high conviction | Q2 2019 | – | +0.4 pts |
| Caption Management, LLC | Q2 2019 | – | −0.2 pts |
| RA Capital Management, L.P. | Q1 2018 | – | −0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.